Fabtech Technologies Limited announces resignation of CFO Kalpesh Chauhan
Fabtech Technologies · Healthcare Services
Key highlights
- Kalpesh Chauhan resigned as Chief Financial Officer and Key Managerial Personnel
- Resignation effective from close of business hours on November 12, 2026
- Reason for resignation cited as personal/professional reasons
Why it's rated notable: The filing states a resignation of the CFO and KMP effective November 12, 2026, with no amount stated, so the level stays at medium.
Original filing
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other management change filings this fortnight
- Prima Plastics Limited announces board meeting outcomes and appointments/resignation
- Prozone Realty announces resignation of CFO Anurag Garg and Independent Director Dipa Hetal Hakani
- Veedol Corporation Limited announces MD change and approves Q2 FY2027 results
- Sundaram Finance Chairman S. Viji resigns, R. Venkatraman appointed new Chairman
- TPL Plastech Ltd appoints new CEO; approves quarterly financials ending Sept 2026
- Upsurge Investment and Finance Limited CFO Mayank Goyal resigns effective 4 Nov 2026
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.